A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial

Veure altres versions (1)

Objective: To study the immunogenicity and reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine (Hib-MenC-TT) when administered as a booster dose in combination with a measles, mumps and rubella vaccine (MMR). Design: A ph...

Descripció completa

Dades bibliogràfiques
Autors principals:	Pace, D, Snape, M, Westcar, S, Oluwalana, C, Yu, L, Begg, N, Wysocki, J, Czajka, H, Maechler, G, Boutriau, D, Pollard, A
Format:	Journal article
Idioma:	English
Publicat:	BMJ Publishing Group 2008
Matèries:	Vaccinology Medical sciences Paediatrics

Ítems similars

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.
per: Pace, D, et al.
Publicat: (2008)

Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
per: Khatami, A, et al.
Publicat: (2012)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
per: Snape, M, et al.
Publicat: (2006)

Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.
per: Khatami, A, et al.
Publicat: (2013)

What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries?
per: Scott, J, et al.
Publicat: (2008)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
per: Lee, Y, et al.
Publicat: (2006)

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial
per: Perrett, K, et al.
Publicat: (2010)

Immunogenicity and safety of a low-dose diphtheria, tetanus and acelular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
per: Collins, C, et al.
Publicat: (2004)

Quadrivalent meningococcal conjugate vaccines
per: Pace, D, et al.
Publicat: (2009)

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
per: Pulickal, A, et al.
Publicat: (2007)

Sustaining immunity after immunization against encapsulated bacteria
per: Blanchard-Rohner, G, et al.
Publicat: (2008)

Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria
per: Sadarangani, M, et al.
Publicat: (2011)

Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal
per: Pulickal, A, et al.
Publicat: (2009)

A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase
per: Riddell, A, et al.
Publicat: (2007)

Vaccine prevention of meningococcal disease, coming soon?
per: Morley, S, et al.
Publicat: (2001)

Vaccines against bacterial meningitis
per: Segal, S, et al.
Publicat: (2004)

Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
per: Pollard, A, et al.
Publicat: (2009)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
per: Diggle, L, et al.
Publicat: (2006)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
per: Blanchard-Rohner, G, et al.
Publicat: (2010)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
per: Clutterbuck, E, et al.
Publicat: (2006)

Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization
per: Vu, D, et al.
Publicat: (2006)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
per: Ruggeberg, J, et al.
Publicat: (2007)

A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
per: Pace, D, et al.
Publicat: (2007)

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
per: Khatami, A, et al.
Publicat: (2011)

School-aged children: a reservoir for continued circulation of Haemophilus influenzae Type b in the United Kingdom
per: Oh, S, et al.
Publicat: (2008)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
per: Lee, Y, et al.
Publicat: (2008)

Global epidemiology of meningococcal disease and vaccine efficacy
per: Pollard, A
Publicat: (2004)

Genetics determinants of vaccine responses
per: O'Connor, D
Publicat: (2014)

Is Diphtheria Booster Vaccination Still Necessary in Turkey?
per: Sule Eren CAKAR, et al.
Publicat: (2018-12-01)

B cell response to pneumococcal vaccines
per: Trück, J
Publicat: (2014)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
per: Pollard, A, et al.
Publicat: (2004)

Editorial: Reverse Vaccinology
per: Richard Moxon, et al.
Publicat: (2019-12-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
per: Pinpathomrat, N
Publicat: (2018)

The Vaccinia Virus A36R Protein Is a Type Ib Membrane Protein Present on Intracellular but Not Extracellular Enveloped Virus Particles
per: Van Eijl, H, et al.
Publicat: (2000)

The Effects of Targeting the Vaccinia Virus B5R Protein to the Endoplasmic Reticulum on Virus Morphogenesis and Dissemination
per: Mathew, E, et al.
Publicat: (1999)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
per: Warrell, M, et al.
Publicat: (2008)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
per: Pace, D, et al.
Publicat: (2016)

Mapping Potential Vaccine Candidates Predicted by VaxiJen for Different Viral Pathogens between 2017–2021—A Scoping Review
per: Zakia Salod, et al.
Publicat: (2022-10-01)

VPAgs-Dataset4ML: A Dataset to Predict Viral Protective Antigens for Machine Learning-Based Reverse Vaccinology
per: Zakia Salod, et al.
Publicat: (2023-02-01)

Emerging Vaccine Technologies
per: Rebecca J. Loomis, et al.
Publicat: (2015-05-01)